Literature DB >> 19010564

Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis.

Felix Stickel1, Sara Droz, Eleonora Patsenker, Katja Bögli-Stuber, Beat Aebi, Stephen L Leib.   

Abstract

BACKGROUND/AIMS: Nutritional supplements are widely used. Recently, liver injury after consumption of Herbalife preparations was reported but the underlying pathogenesis remained cryptic.
METHODS: Two patients presented with cholestatic hepatitis and pruritus, and cirrhosis, respectively. Viral, alcoholic, metabolic, autoimmune, neoplastic, vascular liver diseases and synthetic drugs as the precipitating causes of liver injury were excluded. However, both patients reported long-term consumption of Herbalife products. All Herbalife products were tested for contamination with drugs, pesticides, heavy metals, and softeners, and examined for microbial contamination according to standard laboratory procedures. Bacteria isolated from the samples were identified as Bacillus subtilis by sequencing the 16S rRNA and gyrB genes.
RESULTS: Causality between consumption of Herbalife products and disease according to CIOMS was scored "probable" in both cases. Histology showed cholestatic and lobular/portal hepatitis with cirrhosis in one patient, and biliary fibrosis with ductopenia in the other. No contamination with chemicals or heavy metals was detected, and immunological testing showed no drug hypersensitivity. However, samples of Herbalife products ingested by both patients showed growth of Bacillus subtilis of which culture supernatants showed dose- and time-dependent hepatotoxicity.
CONCLUSIONS: Two novel incidents of severe hepatic injury following intake of Herbalife products contaminated with Bacillus subtilis emphasize its potential hepatotoxicity.

Entities:  

Mesh:

Year:  2008        PMID: 19010564     DOI: 10.1016/j.jhep.2008.08.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  29 in total

1.  Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests.

Authors:  Rolf Teschke; Christian Frenzel; Johannes Schulze; Alexander Schwarzenboeck; Axel Eickhoff
Journal:  World J Hepatol       Date:  2013-07-27

2.  Catechins in dietary supplements and hepatotoxicity.

Authors:  Victor J Navarro; Herbert L Bonkovsky; Sun-Il Hwang; Maricruz Vega; Huiman Barnhart; Jose Serrano
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

Review 3.  Herbal hepatotoxicity: a hidden epidemic.

Authors:  Anna Licata; Fabio Salvatore Macaluso; Antonio Craxì
Journal:  Intern Emerg Med       Date:  2012-04-04       Impact factor: 3.397

4.  Safety assessment of the dietary supplement OxyELITE™ Pro (New Formula) in inbred and outbred mouse strains.

Authors:  Isabelle R Miousse; Charles M Skinner; Haixia Lin; Laura E Ewing; Stanley D Kosanke; D Keith Williams; Bharathi Avula; Ikhlas A Khan; Mahmoud A ElSohly; Bill J Gurley; Igor Koturbash
Journal:  Food Chem Toxicol       Date:  2017-08-24       Impact factor: 6.023

5.  Revisiting acute liver injury associated with herbalife products.

Authors:  Kristy Appelhans; Casey Smith; Ezra Bejar; Y Steve Henig
Journal:  World J Hepatol       Date:  2011-10-27

Review 6.  Herbal and Dietary Supplement-Induced Liver Injury.

Authors:  Ynto S de Boer; Averell H Sherker
Journal:  Clin Liver Dis       Date:  2016-10-14       Impact factor: 6.126

7.  Acute liver injury induced by weight-loss herbal supplements.

Authors:  Gary C Chen; Vivek S Ramanathan; David Law; Pauline Funchain; George C Chen; Samuel French; Boris Shlopov; Viktor Eysselein; David Chung; Sonya Reicher; Binh V Pham
Journal:  World J Hepatol       Date:  2010-11-27

8.  Herbal medicine-related hepatotoxicity.

Authors:  Evangelos Stournaras; Konstantinos Tziomalos
Journal:  World J Hepatol       Date:  2015-09-08

Review 9.  Recent Advances in the Histopathology of Drug-Induced Liver Injury.

Authors:  David E Kleiner
Journal:  Surg Pathol Clin       Date:  2018-06

10.  Complementary and alternative medicine use in chronic liver disease patients.

Authors:  Leah M Ferrucci; Beth P Bell; Kathy B Dhotre; M Michele Manos; Norah A Terrault; Atif Zaman; Rosemary C Murphy; Grace R Vanness; Ann R Thomas; Stephanie R Bialek; Mayur M Desai; Andre N Sofair
Journal:  J Clin Gastroenterol       Date:  2010-02       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.